AbCellera Biologics Inc. Common Shares

ABCLNASDAQ • USD
11.25 USD
↘ 0.24 (2.09%)🟢PRE MARKET (AS OF 07:59 AM EST)
🟢Market: OPEN

AbCellera Biologics Inc. Common Shares (ABCL) trades at $11.25 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$11.48
High?$11.48
Low?$11.21
Prev. Close?$11.49
Volume?37.7K
Avg. Volume?3.9M
VWAP?$11.30
Rel. Volume?0.01x
Bid / Ask
Bid?$9.58 × 100
Ask?$13.29 × 100
Spread?$3.71
Midpoint?$11.43
Valuation & Ratios
Market Cap?3.8B
Shares Out?326.6M
Float?212.8M
Float %?69.4%
P/E Ratio?N/A
P/B Ratio?3.53
EPS?-$0.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Employees
562
Market Cap
3.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-12-11
Address
150 W 4TH AVENUE
VANCOUVER, A1 V5Y 1G6
Phone: (604) 559-9005
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
99
Momentum?
50
Short Sent.?
59
Piotroski F-Score?3/9Weak
Altman Z-Score?5.24Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.64%High
Short Interest?29.0M
Days to Cover?8.5
Free Float212.8M
Avg Daily Volume3.4M
Settlement Date2026-10-30
Financial Health
Current Ratio?12.43Strong
Quick Ratio?12.43Strong
Cash Ratio?2.32Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
49
3.53FAIR▾
P/S?
Peers
100
S&P
3
55.31HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-20.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
52.89HIGH▾
Returns & Efficiency
ROE?
S&P
9
-14.0%WEAK▾
ROA?
S&P
3
-9.9%WEAK▾
Cash Flow & Enterprise
FCF?$-32850000
Enterprise Value?$3.6B
Fundamentals ratios updated end of day